Geode Capital Management, LLC Novan, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.41 - $1.4 $34,482 - $117,745	84,104 Added 55.9%	234,555 $100,000
Q4 2022 Feb 13, 2023	BUY	$0.82 - $1.48 $4,602 - $8,307	5,613 Added 3.88%	150,451 $219,000
Q1 2022 May 13, 2022	BUY	$2.95 - $4.41 $35,220 - $52,650	11,939 Added 8.98%	144,838 $570,000
Q4 2021 Feb 11, 2022	SELL	$4.03 - $8.15 $7,193 - $14,547	-1,785 Reduced 1.33%	132,899 $554,000
Q3 2021 Nov 12, 2021	BUY	$7.48 - $10.17 $87,673 - $119,202	11,721 Added 9.53%	134,684 $1.1 Million

Q2 2021 Aug 13, 2021	BUY	$7.8 - $17.35 $959,111 - $2.13 Million	122,963 New	122,963 $1.24 Million

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.